Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Calcium hydroxide + iodoform is a combination dental material widely used as an intracanal medicament and root canal filling material, particularly in pediatric endodontics. Calcium hydroxide acts by dissociating into calcium and hydroxyl ions, creating a high pH environment that is antimicrobial and promotes tissue healing and biomineralization. Iodoform contributes radiopacity to the mixture and provides additional antibacterial properties. The combination is resorbable when extruded beyond the apex of primary teeth, making it suitable for use in pulpectomy procedures for primary teeth nearing exfoliation. The addition of iodoform improves handling characteristics and radiographic visibility but does not significantly enhance the antimicrobial effect compared to calcium hydroxide alone[1][3][6][8]. Commercially available products include Vitapex (Diadent) and Neopex (Orikam Healthcare). This combination is primarily indicated for temporary or permanent root canal fillings, apexification, pulp capping, control of weeping canals/exudation, management of root resorption cases, and treatment of periapical lesions[10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on calcium hydroxide + iodoform.